Abstract
It is easy to detail our society’s expectations of a medical specialty. We expect that the field will put the interests of patients—and thus of society—first. This public interest should trump the field’s interests as a guild. As such, we expect that the leaders of the specialty will provide the public with accurate information about the nature of the disorders they treat, and about the risks and benefits of treatments. We also expect that the profession will conduct research designed to improve the care it is able to provide, and that it will follow the dictates of good science as it pursues that goal.
Health care workers are obliged to use the best medical science to relieve suffering and pain, treat illness, and address risks to health. The institutional corruption of health care consists of deviations from these principles.
—Donald Light, 20131
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
D. Light. “Institutional corruption of pharmaceuticals and the myth of safe and effective drugs.” J Law Med Ethics 41 (2013): 590–600.
G. Klerman. “The Evolution of a Scientific Nosology,” in Schizophrenia: Science and Practice, edited by J. Shershow (Cambridge, MA: Harvard University Press, 1978): 104–5.
R. Spitzer. “A re-analysis of the reliability of psychiatric diagnosis.” Br J Psychiatry 125 (1974): 341–7.
As cited by S. Kirk, The Selling of DSM (Hawthorne, NY: Aldine de Gruyter, 1992): 124.
R. Spitzer. “DSM-III field trials:1. Initial interrater diagnostic reliability.” Am J Psychiatry 136 (1979): 815–17.
R. Spitzer. “DSM-III. The major achievements and an overview.” Am J Psychiatry 137 (1980): 151–64.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, third edition (Washington, DC: American Psychiatric Association, 1980): 5, 468.
G. Klerman. “A debate on DSM-III.” Am J Psychiatry 141 (1984): 539–53.
D. Langsley. “Presidential address: today’s teachers and tomorrow’s psychiatrists.” Am J Psychiatry 138 (1981): 1013–16.
M. Strand. “Where do classifications come from? The DSM-III, the transformation of American psychiatry, and the problem of origins in the sociology of knowledge.” Theor Soc 40 (2011): 273–313.
M. Rutter. “DSM-III: a step forward or back in terms of the classification of child psychiatric disorders?” J Am Acad Child Psychiatry 19 (1980): 371–94.
H. Decker. The Making of DSM-III (New York: Oxford University Press, 2013): 258.
A. Bassett. “DSM-III: use of the multiaxial system in clinical practice.” Can J Psychiatry 36 (1991): 270–4.
P. Lieberman. “The reliability of psychiatric diagnosis in the emergency room.” Hosp Community Psychiatry 36 (1985): 291–3.
J. Anthony. “Comparison of the lay diagnostic interview schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore.” Arch Gen Psychiatry 42 (1985): 667–75.
J. Talbott. “Presidential address: our patients’ future in a changing world.” Am J Psychiatry 142 (1985): 1003–8.
Associated Press. “Researcher says treatment may be near for depression,” October 12, 1981.
N. Andreasen. The Broken Brain (New York: Harper & Row, 1984): 29.
C. Nadelson. “Response to the presidential address.” Am J Psychiatry 142 (1985): 1009–14.
D. Regier. “The NIMH depression awareness, recognition, and treatment program.” Am J Psychiatry 145 (1988): 1351–7.
D. Healy, Let Them Eat Prozac (New York: New York University Press, 2004): 9.
J. Lacasse. “Serotonin and depression: a disconnect between the advertisements and the scientific literature.” PLoS Med 2 (2005): 1211–16.
P. Weiden, Breakthroughs in Antipsychotics Medications (New York: W.W. Norton, 1999): 26, 29.
American Psychiatric Association. “Mental illness stigmas are receding,” press release, May 4, 2005.
American Psychiatric Association. “Let’s talk facts about depression,” 2005.
B. Pescosolido. “A disease like any other?” Am J Psychiatry 167 (2010): 1321–30; see table 1, p. 1324.
M. Bowers. “Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.” J New Ment Disease 158 (1974): 325–30.
R. Papeschi. “Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients.” Arch Gen Psychiatry 25 (1971): 354–8.
J. Mendels. “Brain biogenic amine depletion and mood.” Arch Gen Psychiatry 30 (1974): 447–51.
J. Maas. “Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.” Am J Psychiatry 141 (1984): 1159–71.
S. Dubovsky. “Mood disorders,” in Textbook of Psychiatry, edited by R. Hales, third edition (Washington, DC: American Psychiatric Press, 1999): 516.
V. Krishnan. “Linking molecules to mood.” Am J Psychiatry 167 (2010): 1305–20.
National Public Radio. “When it comes to depression, serotonin isn’t the whole story.” January 23, 2012.
M. Bowers. “Central dopamine turnover in schizophrenic syndromes.” Arch Gen Psychiatry 31 (1974): 50–4.
R. Post. “Cerebrospinal fluid amine metabolites in acute schizophrenia.” Arch Gen Psychiatry 32 (1975): 1063–9.
T. Lee. “Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.” Nature 274 (1978): 897–900.
J. Kornhuber. “3H-spiperone binding sites in post-mortem brains from schizophrenic patients.” J Neural Transmission 75 (1989): 1–10.
J. Kane. “Towards more effective antipsychotic treatment.” Br J Psychiatry 165, suppl. 25 (1994): 22–31.
E. Nestler, Molecular Neuropharmacology (New York: McGraw Hill, 2001): 392.
A. Jucaite. “Dopaminergic hypothesis of schizophrenia,” in Emerging Therapies for Schizophrenia, edited by J. Albert (Hoboken, NJ: John Wiley & Sons, 2012): 5–35.
T. Insel. “Director’s blog: mental illness defined as disruption in neural circuits.” Published on nimh.nih.gov, August 12, 2011.
R. Pies. “Doctor, is my mood disorder due to a chemical imbalance?” Blog, August 4, 2011, published on PsychCentral.com.
M. England. “Response to the presidential address: one system of equal health care for all.” Am J Psychiatry 152 (1995): 1252–3.
N. Andreasen, editorial. “The validation of psychiatric diagnosis.” Am J Psychiatry 152 (1995): 161–2.
C. Robinowitz. “ Response to the presidential address.” Am J Psychiatry 164 (2007): 1510–13.
J. Phillips. “The six most essential questions in psychiatric diagnosis: a pluralogue part 2.” Philosophy Ethics Humanities Med 7 (2012): 8.
J. Phillips. “The six most essential questions in psychiatric diagnosis: a pluralogue part 1.” Philosophy Ethics Humanities Med 7 (2012): 3.
T. Insel. “Director’s blog: transforming diagnosis.” Published on nimh.nih.gov, April 29, 2013.
N. Andreasen. “DSM and the death of phenomenology.” Schizophrenia Bull 33 (2007): 108–12.
Copyright information
© 2015 Robert Whitaker and Lisa Cosgrove
About this chapter
Cite this chapter
Whitaker, R., Cosgrove, L. (2015). The Etiology of Mental Illness Is Now Known. In: Psychiatry Under the Influence. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137516022_4
Download citation
DOI: https://doi.org/10.1057/9781137516022_4
Publisher Name: Palgrave Macmillan, New York
Print ISBN: 978-1-349-50598-2
Online ISBN: 978-1-137-51602-2
eBook Packages: Palgrave Social Sciences CollectionSocial Sciences (R0)